D-1353-2022 Class III Terminated

Recalled by Akron Pharma, Inc. — Fairfield, NJ

FDA drug recall D-1353-2022 was initiated by Akron Pharma, Inc. on Aug 4, 2022 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet. The recall status is terminated (terminated Dec 4, 2023). Affected quantity: 30,325 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 24, 2022
Initiation Date
Aug 4, 2022
Termination Date
Dec 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30,325 bottles

Product description

Acetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (NDC 71399-8022-01), b) 1000-count bottle (NDC 71399-8022-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc., Fairfield, NJ

Reason for recall

Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.

Distribution pattern

Product was distributed to 6 distributors/wholesalers who may have further distributed the product.

Code information

Lot#: AXA2014, Exp Feb-23; AXB2001, Exp Nov-22; AXB2002, AXB2003, AXB2004, AXB2005, AXB2006, AXB2007, AXB2008, AXB2009, AXB2010, AXB2011, Exp Dec-22; AXB2012, AXB2013, AXB2014, AXB2015, AXB2016, AXB2017, AXB2018, AXB2019, AXB2020, AXB2021, AXB2022, AXB2023, AXB2024, AXB2025, AXB2026, AXB2027, Exp Feb-23

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1353-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1353-2022. Report a data issue: hello@regdatalab.com.